Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients.
Asleh R, Briasoulis A, Kremers WK, Adigun R, Boilson BA, Pereira NL, Edwards BS, Clavell AL, Schirger JA, Rodeheffer RJ, Frantz RP, Joyce LD, Maltais S, Stulak JM, Daly RC, Tilford J, Choi WG, Lerman A, Kushwaha SS. Asleh R, et al. Among authors: choi wg. J Am Coll Cardiol. 2018 Feb 13;71(6):636-650. doi: 10.1016/j.jacc.2017.12.005. J Am Coll Cardiol. 2018. PMID: 29420960 Free article.
P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trial.
Roh JW, Hahn JY, Oh JH, Chun WJ, Park YH, Jang WJ, Im ES, Jeong JO, Cho BR, Oh SK, Yun KH, Cho DK, Lee JY, Koh YY, Bae JW, Choi JW, Lee WS, Yoon HJ, Lee SU, Cho JH, Choi WG, Rha SW, Kim HY, Lee JM, Park TK, Yang JH, Choi JH, Choi SH, Lee SH, Gwon HC, Kim DB, Song YB. Roh JW, et al. Among authors: choi jh, choi jw, choi sh, choi wg. Cardiol J. 2021;28(6):855-863. doi: 10.5603/CJ.a2021.0101. Epub 2021 Sep 15. Cardiol J. 2021. PMID: 34523115 Free PMC article. Clinical Trial.
Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial.
Choi KH, Park YH, Song YB, Park TK, Lee JM, Yang JH, Choi JH, Choi SH, Oh JH, Chun WJ, Jang WJ, Im ES, Jeong JO, Cho BR, Oh SK, Yun KH, Cho DK, Lee JY, Koh YY, Bae JW, Choi JW, Lee WS, Yoon HJ, Lee SU, Cho JH, Choi WG, Rha SW, Gwon HC, Hahn JY; SMART-CHOICE Investigators. Choi KH, et al. Among authors: choi jh, choi jw, choi sh, choi wg. JAMA Cardiol. 2022 Nov 1;7(11):1100-1108. doi: 10.1001/jamacardio.2022.3203. JAMA Cardiol. 2022. PMID: 36169938 Free PMC article.
Additional postdilatation using noncompliant balloons after everolimus-eluting stent implantation: Results of the PRESS trial.
Park GM, Lee JH, Choi SW, Jeong JO, Shin ES, Bae JW, Yoon HJ, Jung KT, Baek JY, Choi WG, Choi RK, Her SH, Lee JB, Suh J, Lee JB, Lee SW, Chae IH, Choi SY, Seong IW. Park GM, et al. Among authors: choi rk, choi sw, choi sy, choi wg. Clin Cardiol. 2020 Jun;43(6):606-613. doi: 10.1002/clc.23355. Epub 2020 Mar 16. Clin Cardiol. 2020. PMID: 32176364 Free PMC article. Clinical Trial.
Safety of 3-Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus-Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART-CHOICE Trial.
Yun KH, Lee SY, Cho BR, Jang WJ, Song YB, Oh JH, Chun WJ, Park YH, Im ES, Jeong JO, Oh SK, Cho DK, Lee JY, Koh YY, Bae JW, Choi JW, Lee WS, Yoon HJ, Lee SU, Cho JH, Choi WG, Rha SW, Lee JM, Park TK, Yang JH, Choi JH, Choi SH, Lee SH, Gwon HC, Hahn JY; SMART‐CHOICE Investigators [Link]. Yun KH, et al. Among authors: choi jh, choi jw, choi sh, choi wg. J Am Heart Assoc. 2021 Jan 5;10(1):e018366. doi: 10.1161/JAHA.120.018366. Epub 2020 Dec 21. J Am Heart Assoc. 2021. PMID: 33345567 Free PMC article. Clinical Trial.
Five-year major clinical outcomes between first-generation and second-generation drug-eluting stents in acute myocardial infarction patients underwent percutaneous coronary intervention.
Kim YH, Her AY, Rha SW, Choi BG, Choi SY, Byun JK, Baek JY, Choi WG, Kang TS, Ahn JH, Park SH, Mashaly A, Na JO, Choi CU, Lim HE, Kim EJ, Park CG, Seo HS, Oh DJ. Kim YH, et al. Among authors: choi sy, choi bg, choi wg, choi cu. J Geriatr Cardiol. 2018 Aug;15(8):523-533. doi: 10.11909/j.issn.1671-5411.2018.08.006. J Geriatr Cardiol. 2018. PMID: 30344532 Free PMC article.
Five-year clinical outcomes of first-generation versus second-generation drug-eluting stents following coronary chronic total occlusion intervention.
Kim YH, Her AY, Rha SW, Choi BG, Choi SY, Byun JK, Park Y, Kang DO, Jang WY, Kim W, Baek JY, Choi WG, Kang TS, Ahn J, Park SH, Park JY, Lee MH, Choi CU, Park CG, Seo HS. Kim YH, et al. Among authors: choi sy, choi bg, choi wg, choi cu. J Geriatr Cardiol. 2019 Aug;16(8):639-647. doi: 10.11909/j.issn.1671-5411.2019.08.006. J Geriatr Cardiol. 2019. PMID: 31555332 Free PMC article.
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial.
Lee SJ, Cha JJ, Choi WG, Lee WS, Jeong JO, Choi S, Cho YH, Park W, Yoon CH, Lee YJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y, Hong SJ, Kim JS; RACING Investigators. Lee SJ, et al. Among authors: choi wg, choi d, choi s. JAMA Cardiol. 2023 Sep 1;8(9):853-858. doi: 10.1001/jamacardio.2023.2222. JAMA Cardiol. 2023. PMID: 37531130 Free PMC article. Clinical Trial.
Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
Park JB, Koo BK, Choi WG, Kim SY, Park J, Kwan J, Park CG, Kim HS. Park JB, et al. Among authors: choi wg. Clin Ther. 2013 Jan;35(1):28-37.e4. doi: 10.1016/j.clinthera.2012.12.004. Clin Ther. 2013. PMID: 23328268 Clinical Trial.
150 results